Questions have been raised about how Australia ensures the quality of its imported medicines after a major pharmaceutical ...

The US Food and Drug Administration (FDA) admonished Sun Pharmaceutical Industries in a recent warning ... These violations prompted FDA to place the firm on import alert on 7 December. FDA inspected ...

In a warning letter, the FDA has highlighted a series of lapses at Sun Pharma’s Gujarat plant, which has been put on an import alert list by the US drug regulator. In the letter dated December ...

The company intends to increase its specialty drug portfolio in its core areas of dermatology and ophthalmology. This comes at a time when the company’s generic business continues to face pricing ...

Sun Pharmaceutical, one of the world’s largest generic drugmakers, was scolded by the U.S. Food and Drug Administration for a host of serious manufacturing violations at a key plant in India ...

The Food and Drug Administration is continuing its use of import alerts to enforce U.S. food safety regulations for food from foreign countries. The agency updates and modifies the alerts as needed.

India's largest drugmaker Sun Pharmaceuticals Ltd. is likely to report a healthy quarter despite the weakness from its ...

According to an ETNow poll, the drugmakers consolidated revenue for the quarter ended December is seen rising 12.5% on-year to Rs 11,100 crore ...

A Boca Raton pharmaceutical company has agreed to settle charges with the Food and Drug Administration that allege improper ...

"Sun Pharma’s immediate focus would be to follow Concert’s plan to submit a New Drug Application (NDA) to the USFDA in the ...

Read more about Sun Pharma to Acquire Concert Pharmaceuticals, Advancing the Potential Treatment of Alopecia Areata on Devdiscourse ...

It prefers pharma companies with clear FDA (Food and Drug Administration ... the largest imported commodity in the US. Value of import of pharma products from India has increased at an 8% CAGR ...